雅虎香港 搜尋

登入

搜尋結果

  1. www.advanzpharma.comWelcome to ADVANZ PHARMA

    ADVANZ PHARMA’s product portfolio and pipeline comprises innovative medicines, specialty generics & biosimilars, and originator brands. Our products and pipeline cover a broad range of therapeutic areas, including hepatology, gastroenterology, anti-infectives, critical care, endocrinology, CNS, and, more broadly, rare diseases.

    • About

      ADVANZ PHARMA is a global pharmaceutical company with ...

    • News

      Press Releases — ADVANZ PHARMA and Allecra ...

    • Partner of Choice

      ADVANZ PHARMA‘s capabilities: Direct presence in ...

    • Investors

      You are leaving the ADVANZ PHARMA site If you agree, ...

  2. en.wikipedia.org › wiki › Advanz_PharmaAdvanz Pharma - Wikipedia

    Advanz Pharma Corp. is a British multinational pharmaceutical company headquartered in London. It changed its name from Concordia Healthcare Corp. in November 2018. [ 3 ] The company focuses on a number of therapy areas including endocrinology , ophthalmology , urology , anti-infectives , pain management , central nervous system ...

  3. 其他人也問了

  4. www.advanzpharma.com › aboutAbout - ADVANZ PHARMA

    ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing the specialty, hospital, and rare disease medicines they depend on. Our ambition is to be a partner of choice for the commercialisation of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia.

    • advanz pharma1
    • advanz pharma2
    • advanz pharma3
    • advanz pharma4
    • advanz pharma5

  5. www.linkedin.com › company › advanz-pharmaADVANZ PHARMA - LinkedIn

    Partner of choice in specialty, hospital, and rare disease medicines ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing the specialty ...

  6. bnmgroup.advanzpharma.com › newsNews - ADVANZ PHARMA

    ADVANZ PHARMA and Allecra Therapeutics announce approval in the European Union for the new antibiotic combination EXBLIFEP® (cefepime/enmetazobactam) for the treatment of severe infections

    • advanz pharma1
    • advanz pharma2
    • advanz pharma3
    • advanz pharma4
    • advanz pharma5

  7. investors.advanzpharma.com › news › 2024Alvotech and ADVANZ PHARMA Sign Commercialization Agreement ...

    2024年6月18日 · ADVANZ PHARMA secures rights to commercialize Alvotech’s biosimilar candidate for Eylea® in Europe. ADVANZ PHARMA will leverage its existing specialty and hospital capabilities in Europe to ensure successful market registration, commercialization, and patient access. REYKJAVIK, ICELAND and LONDON, UK (June 18, 2024) — Alvotech ...

  8. hk.linkedin.com › company › advanz-pharmaADVANZ PHARMA - LinkedIn

    ADVANZ PHARMA | 39,871 followers on LinkedIn. Partner of choice in specialty, hospital, and rare disease medicines | Partner of choice in specialty, hospital, and rare disease medicines ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing the specialty, hospital, and rare disease medicines they depend on. Our ambition is to be a partner of ...